ERAP1-DERIVED PEPTIDE AND USE THEREOF

• 收藏
• 分享

专利权人:

THE UNIVERSITY OF TOKUSHIMA

发明人:

KATAGIRI, TOYOMASA,TSUNODA, TAKUYA

申请号：

EP12820786

公开号：

EP2738255A4

申请日:

2012.07.27

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

Provided is a novel cancer therapeutic agent which can be used as a novel choice for the treatment of cancer. Specifically provided are: a peptide which comprises a binding site for a PHB2 polypeptide in an ERAP1 polypeptide and can inhibit the binding between the ERAP1 polypeptide and the PHB2 polypeptide a pharmaceutical composition containing the peptide and a method for screening for a drug candidate for treating and/or preventing cancer, in which the inhibition of the binding between an ERAP1 polypeptide and a PP1α polypeptide, a PKA polypeptide or a PKB polypeptide is employed as a measure.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/